Phenotypic changes in dorsal root ganglion and spinal cord in the collagen antibody-induced arthritis mouse model

2015 ◽  
Vol 523 (10) ◽  
pp. 1505-1528 ◽  
Author(s):  
Jie Su ◽  
Tianle Gao ◽  
Tiejun Shi ◽  
Qiong Xiang ◽  
Xiaojun Xu ◽  
...  
2012 ◽  
Vol 71 (Suppl 1) ◽  
pp. A31.2-A32
Author(s):  
J Su ◽  
T J Shi ◽  
T L Gao ◽  
Z Wiesenfeld-Hallin ◽  
T Hökfelt ◽  
...  

2018 ◽  
Vol 36 (2) ◽  
pp. 110-116 ◽  
Author(s):  
Liang-Ta Yen ◽  
Yu-Chan Hsu ◽  
Jaung-Geng Lin ◽  
Ching-Liang Hsieh ◽  
Yi-Wen Lin

Background The mechanisms underlying fibromyalgia (FM) pain are not understood. The US Food and Drug Administration has recommended three drugs for treating FM—namely, pregabalin, duloxetine and milnacipran; however, these medications are associated with severe side effects. Objective To create a mouse model of FM pain using dual injections of acidic saline to cause mechanical hyperalgesia and test whether ASIC3, Nav1.7 and Nav1.8 are involved in this process and whether electroacupuncture (EA) can reverse these phenomena. Methods The FM model was established by injecting acidic saline twice into 40 ICR mice. The mice were assigned to subgroups (n=8 each) treated with different EA frequencies (2, 15 and 50 Hz). ASIC3, Nav1.7 and Nav1.8 expression levels were measured by Western blotting and immunohistochemistry. Results Significant mechanical hyperalgesia was induced on day 8 in FM mice, which was reversed by 2, 15 and 50 Hz EA. ASIC3, Nav1.7 and Nav1.8 protein levels increased significantly in both the dorsal root ganglion and in the spinal cord of FM model mice. These changes were further attenuated by 2, 15 and 50 Hz EA. Conclusion Reduced nociceptive ASIC3, Nav1.7 and Nav1.8 proteins are involved in the preventive effects of EA against FM, and this series of molecules may represent targets for FM treatment.


Author(s):  
Vishwanath Sankarasubramanian ◽  
Srinivas Chiravuri ◽  
Ehsan Mirzakhalili ◽  
Carlos J. Anaya ◽  
John Ryan Scott ◽  
...  

Author(s):  
Jonathan M. Hagedorn ◽  
Brittney Misercola ◽  
Ashley Comer ◽  
Jeanmarie Tari-Blake ◽  
Chelsey M. Hoffmann ◽  
...  

2000 ◽  
Vol 1 (5) ◽  
pp. 464-478 ◽  
Author(s):  
Daniel R. Marsh ◽  
Gregory A. Dekaban ◽  
Wei Tan ◽  
Craig A. Strathdee ◽  
Lynne C. Weaver

2005 ◽  
Vol 131 (1-3) ◽  
pp. 66-73 ◽  
Author(s):  
Ching-Liang Lu ◽  
Pankaj J. Pasricha ◽  
Jen-Chuen Hsieh ◽  
Ray-Hwa Lu ◽  
Chun-Ru Lai ◽  
...  

2021 ◽  
Vol 14 (5) ◽  
pp. e241353
Author(s):  
Gaurav Chauhan ◽  
Brandon I Roth ◽  
Nagy Mekhail

Dorsal root ganglion stimulation (DRGS) therapy is a rapidly emerging tool being used by pain physicians in the treatment of chronic pain. Complex regional pain syndrome (CRPS), a debilitating disease whose mechanism is still has yet to be fully elucidated, is a common pathology targeted by DRGS therapy, often better results than traditional spinal cord stimulation. DRGS therapy, however, is not bereft of complications. Lead migration and fracture are two examples in particular that are among the most common of these complications. The authors report an unusual case of lost efficacy due to lead fractures in patients with CRPS treated with DRGS. The case report narrates identification, management and probable mechanism of DRGS lead fracture. The structural instability of DRGS leads can yield distressing symptoms at any point during the therapy, and physicians should be cognisant of the complications of DRGS therapy.


Sign in / Sign up

Export Citation Format

Share Document